CONMED CORPORATION Earnings Per Share (Diluted)
CONMED CORPORATION (CNMD) reported Earnings Per Share (Diluted) of $0.77 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-29
- CONMED CORPORATION earnings per share, diluted for the quarter ending 2026-06-30 was $0.77, a 11.59% increase year-over-year.
- CONMED CORPORATION earnings per share, diluted for the quarter ending 2025-09-30 was $0.09, a 94.27% decline year-over-year.
- CONMED CORPORATION earnings per share, diluted for the quarter ending 2025-06-30 was $0.69, a 28.13% decline year-over-year.
- CONMED CORPORATION earnings per share, diluted for the quarter ending 2025-03-31 was $0.19, a 69.84% decline year-over-year.
- CONMED CORPORATION earnings per share, diluted for fiscal 2025 was $1.51, a 64.47% decline from fiscal 2024.
- CONMED CORPORATION earnings per share, diluted for fiscal 2024 was $4.25, a 108.33% increase from fiscal 2023.
- CONMED CORPORATION earnings per share, diluted for fiscal 2023 was $2.04.
- CONMED CORPORATION earnings per share, diluted for fiscal 2022 was -$2.68, a 238.14% decline from fiscal 2021.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.77 10-Q · filed 2026-07-29 | $1.22 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $1.51 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $0.09 10-Q · filed 2025-11-06 | $0.97 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $0.69 10-Q · filed 2026-07-29 | $0.88 10-Q · filed 2026-07-29 | ||
| 2025-03-31 | $0.19 10-Q · filed 2025-05-01 | |||
| 2024-12-31 | $4.25 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $1.57 10-Q · filed 2025-11-06 | $3.17 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.96 10-Q · filed 2025-07-31 | $1.59 10-Q · filed 2025-07-31 | ||
| 2024-03-31 | $0.63 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $2.04 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $0.50 10-Q · filed 2024-10-31 | $0.93 derived: net income ÷ weighted average shares · filed 2024-10-31 | $0.99 10-Q · filed 2024-10-31 | $1.85 derived: net income ÷ weighted average shares · filed 2025-02-18 |
| 2023-06-30 | $0.43 10-Q · filed 2024-08-01 | $0.49 10-Q · filed 2024-08-01 | $1.35 derived: net income ÷ weighted average shares · filed 2025-02-18 | $2.83 derived: net income ÷ weighted average shares · filed 2025-02-18 |
| 2023-03-31 | $0.06 10-Q · filed 2024-04-25 | $0.92 derived: net income ÷ weighted average shares · filed 2025-02-18 | $2.41 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$3.06 derived: net income ÷ weighted average shares · filed 2025-02-18 |
| 2022-12-31 | $0.87 derived: net income ÷ weighted average shares · filed 2025-02-18 | $2.36 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$3.14 derived: net income ÷ weighted average shares · filed 2025-02-18 | -$2.68 10-K · filed 2025-02-18 |
| 2022-09-30 | $1.48 10-Q · filed 2023-10-26 | -$4.01 derived: net income ÷ weighted average shares · filed 2023-10-26 | -$3.59 10-Q · filed 2023-10-26 | -$2.52 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-06-30 | -$5.65 10-Q · filed 2023-07-27 | -$5.18 10-Q · filed 2023-07-27 | -$3.90 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$3.46 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-03-31 | $0.47 10-Q · filed 2023-04-27 | $1.21 derived: net income ÷ weighted average shares · filed 2024-02-28 | $1.68 derived: net income ÷ weighted average shares · filed 2024-02-28 | $2.09 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2021-12-31 | $0.75 derived: net income ÷ weighted average shares · filed 2024-02-28 | $1.21 derived: net income ÷ weighted average shares · filed 2024-02-28 | $1.62 derived: net income ÷ weighted average shares · filed 2024-02-28 | $1.94 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.47 10-Q · filed 2022-10-27 | $0.87 derived: net income ÷ weighted average shares · filed 2022-10-27 | $1.19 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $0.41 10-Q · filed 2022-07-28 | $0.72 10-Q · filed 2022-07-28 | ||
| 2021-03-31 | $0.31 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | $0.81 10-K · filed 2021-02-22 | $0.32 10-K · filed 2023-02-21 | ||
| 2020-09-30 | $0.23 10-Q · filed 2021-10-28 | -$0.51 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | -$0.96 10-Q · filed 2021-07-29 | -$0.75 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.20 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $0.49 10-K · filed 2021-02-22 | $0.97 10-K · filed 2022-02-22 | ||
| 2019-09-30 | $0.23 10-K · filed 2021-02-22 | $0.47 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | $0.19 10-K · filed 2021-02-22 | $0.23 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $0.04 10-K · filed 2021-02-22 | |||
| 2018-12-31 | $0.54 10-K · filed 2020-02-24 | $1.41 10-K · filed 2021-02-22 | ||
| 2018-09-30 | $0.20 10-K · filed 2020-02-24 | $0.87 10-Q · filed 2019-10-31 | ||
| 2018-06-30 | $0.30 10-K · filed 2020-02-24 | $0.67 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.37 10-K · filed 2020-02-24 | |||
| 2017-12-31 | $1.65 10-K · filed 2019-02-25 | $1.97 10-K · filed 2020-02-24 | ||
| 2017-09-30 | $0.26 10-K · filed 2019-02-25 | $0.31 10-Q · filed 2018-11-02 | ||
| 2017-06-30 | $0.22 10-K · filed 2019-02-25 | $0.06 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | -$0.16 10-K · filed 2019-02-25 | |||
| 2016-12-31 | $0.24 10-K · filed 2018-02-26 | $0.52 10-K · filed 2019-02-25 | ||
| 2016-09-30 | $0.26 10-K · filed 2018-02-26 | $0.28 10-Q · filed 2017-11-02 | ||
| 2016-06-30 | $0.10 10-K · filed 2018-02-26 | $0.02 10-Q · filed 2017-07-27 | ||
| 2016-03-31 | -$0.08 10-K · filed 2018-02-26 | |||
| 2015-12-31 | $0.28 10-K · filed 2017-02-27 | $1.09 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $0.32 10-K · filed 2017-02-27 | $0.81 10-Q · filed 2016-10-28 | ||
| 2015-06-30 | $0.27 10-K · filed 2017-02-27 | $0.49 10-Q · filed 2016-07-28 | ||
| 2015-03-31 | $0.23 10-K · filed 2017-02-27 | |||
| 2014-12-31 | $0.41 10-K · filed 2016-02-23 | $1.16 10-K · filed 2017-02-27 | ||
| 2014-09-30 | $0.07 10-K · filed 2016-02-23 | $0.75 10-Q · filed 2015-10-23 | ||
| 2014-06-30 | $0.37 10-K · filed 2016-02-23 | $0.68 10-Q · filed 2015-07-27 | ||
| 2014-03-31 | $0.31 10-K · filed 2016-02-23 | |||
| 2013-12-31 | $0.36 10-K · filed 2015-02-23 | $1.28 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $0.20 10-K · filed 2015-02-23 | $0.91 10-Q · filed 2014-10-24 | ||
| 2013-06-30 | $0.34 10-K · filed 2015-02-23 | $0.71 10-Q · filed 2014-07-25 | ||
| 2013-03-31 | $0.37 10-K · filed 2015-02-23 | |||
| 2012-12-31 | $0.38 10-K · filed 2014-02-24 | $1.41 10-K · filed 2015-02-23 | ||
| 2012-09-30 | $0.32 10-K · filed 2014-02-24 | $1.03 10-Q · filed 2013-10-28 | ||
| 2012-06-30 | $0.36 10-K · filed 2014-02-24 | $0.71 10-Q · filed 2013-07-29 | ||
| 2012-03-31 | $0.35 10-K · filed 2014-02-24 | |||
| 2011-12-31 | -$0.90 10-K · filed 2013-02-25 | $0.03 10-K · filed 2014-02-24 | ||
| 2011-09-30 | $0.29 10-K · filed 2013-02-25 | $0.90 10-Q · filed 2012-10-29 | ||
| 2011-06-30 | $0.30 10-K · filed 2013-02-25 | $0.61 10-Q · filed 2012-07-30 | ||
| 2011-03-31 | $0.31 10-K · filed 2013-02-25 | |||
| 2010-12-31 | $0.24 10-K · filed 2012-02-28 | $1.05 10-K · filed 2013-02-25 | ||
| 2010-09-30 | $0.31 10-K · filed 2012-02-28 | $0.80 10-Q · filed 2011-11-01 | ||
| 2010-06-30 | $0.25 10-K · filed 2012-02-28 | $0.50 10-Q · filed 2011-08-09 | ||
| 2010-03-30 | $0.25 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $0.42 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |